| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medicare | 115 | 2024 | 6813 | 3.450 |
Why?
|
| Hospitals | 60 | 2024 | 3885 | 2.150 |
Why?
|
| Quality of Health Care | 45 | 2023 | 4306 | 1.620 |
Why?
|
| Cardiomyopathy, Hypertrophic | 18 | 2024 | 1337 | 1.240 |
Why?
|
| Reimbursement Mechanisms | 12 | 2023 | 670 | 1.240 |
Why?
|
| Medicaid | 25 | 2024 | 2836 | 1.170 |
Why?
|
| Reimbursement, Incentive | 9 | 2020 | 541 | 1.140 |
Why?
|
| United States | 209 | 2024 | 72945 | 1.130 |
Why?
|
| Patient Readmission | 29 | 2023 | 3283 | 1.100 |
Why?
|
| Skilled Nursing Facilities | 12 | 2023 | 406 | 1.080 |
Why?
|
| Independent Living | 17 | 2024 | 584 | 1.070 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 7 | 2014 | 685 | 1.030 |
Why?
|
| Accidental Falls | 11 | 2024 | 1077 | 0.950 |
Why?
|
| Health Expenditures | 19 | 2023 | 2389 | 0.940 |
Why?
|
| Aged | 274 | 2024 | 171344 | 0.900 |
Why?
|
| Patient Satisfaction | 26 | 2020 | 3485 | 0.890 |
Why?
|
| Insurance Coverage | 17 | 2024 | 1945 | 0.870 |
Why?
|
| Medicare Part C | 6 | 2024 | 333 | 0.840 |
Why?
|
| Sarcomeres | 9 | 2019 | 379 | 0.820 |
Why?
|
| Female | 416 | 2024 | 396532 | 0.790 |
Why?
|
| Primary Health Care | 30 | 2023 | 4735 | 0.790 |
Why?
|
| Hospital Administration | 8 | 2019 | 351 | 0.780 |
Why?
|
| Humans | 570 | 2024 | 766812 | 0.760 |
Why?
|
| Quality Improvement | 17 | 2024 | 3850 | 0.760 |
Why?
|
| Male | 380 | 2024 | 364154 | 0.760 |
Why?
|
| Ambulatory Care | 24 | 2024 | 2779 | 0.740 |
Why?
|
| Cholecalciferol | 10 | 2024 | 550 | 0.720 |
Why?
|
| Vitamin D | 17 | 2024 | 3270 | 0.710 |
Why?
|
| Health Services Accessibility | 23 | 2024 | 5513 | 0.710 |
Why?
|
| Hospital Mortality | 27 | 2023 | 5344 | 0.700 |
Why?
|
| Somatoform Disorders | 7 | 2013 | 425 | 0.690 |
Why?
|
| Hospitalization | 33 | 2024 | 10816 | 0.690 |
Why?
|
| Frail Elderly | 13 | 2024 | 781 | 0.690 |
Why?
|
| Aged, 80 and over | 121 | 2024 | 59548 | 0.680 |
Why?
|
| Myelodysplastic Syndromes | 5 | 2014 | 1403 | 0.670 |
Why?
|
| Health Care Costs | 17 | 2020 | 3240 | 0.660 |
Why?
|
| Healthcare Disparities | 16 | 2024 | 3411 | 0.640 |
Why?
|
| Hip Fractures | 10 | 2020 | 996 | 0.630 |
Why?
|
| Quality Assurance, Health Care | 14 | 2018 | 2171 | 0.620 |
Why?
|
| Medication Reconciliation | 4 | 2023 | 153 | 0.620 |
Why?
|
| Quality Indicators, Health Care | 14 | 2021 | 1804 | 0.610 |
Why?
|
| Emergency Service, Hospital | 23 | 2024 | 7870 | 0.600 |
Why?
|
| Medical Records Systems, Computerized | 15 | 2009 | 1196 | 0.600 |
Why?
|
| Cardiomyopathy, Dilated | 9 | 2024 | 843 | 0.600 |
Why?
|
| Fee-for-Service Plans | 21 | 2024 | 713 | 0.590 |
Why?
|
| Patient Protection and Affordable Care Act | 12 | 2022 | 1188 | 0.590 |
Why?
|
| Alcoholism | 10 | 2019 | 1980 | 0.580 |
Why?
|
| Anemia, Iron-Deficiency | 4 | 2022 | 372 | 0.580 |
Why?
|
| Vitamins | 10 | 2024 | 1631 | 0.580 |
Why?
|
| Pneumonia | 17 | 2020 | 2161 | 0.570 |
Why?
|
| Hospitals, Teaching | 22 | 2024 | 1156 | 0.520 |
Why?
|
| Middle Aged | 205 | 2024 | 223267 | 0.510 |
Why?
|
| Fatty Acids, Omega-3 | 5 | 2024 | 1399 | 0.500 |
Why?
|
| Medical Order Entry Systems | 7 | 2018 | 523 | 0.500 |
Why?
|
| Medication Errors | 8 | 2019 | 784 | 0.500 |
Why?
|
| Dietary Supplements | 14 | 2024 | 3429 | 0.500 |
Why?
|
| Episode of Care | 7 | 2021 | 127 | 0.480 |
Why?
|
| Adult | 200 | 2024 | 223305 | 0.480 |
Why?
|
| Minority Groups | 5 | 2021 | 1208 | 0.480 |
Why?
|
| Myocardial Infarction | 25 | 2023 | 11514 | 0.470 |
Why?
|
| Coronary Artery Bypass | 5 | 2020 | 2189 | 0.460 |
Why?
|
| Poverty | 11 | 2024 | 2714 | 0.460 |
Why?
|
| Patient Discharge | 16 | 2023 | 3466 | 0.450 |
Why?
|
| Quality of Life | 30 | 2024 | 13476 | 0.440 |
Why?
|
| Patient Acceptance of Health Care | 11 | 2024 | 3230 | 0.440 |
Why?
|
| Private Sector | 2 | 2016 | 396 | 0.430 |
Why?
|
| Patient Admission | 6 | 2018 | 1364 | 0.430 |
Why?
|
| Physicians | 14 | 2022 | 4591 | 0.420 |
Why?
|
| Psychotherapy, Brief | 3 | 2011 | 118 | 0.420 |
Why?
|
| Health Care Surveys | 22 | 2019 | 2425 | 0.410 |
Why?
|
| Surgical Procedures, Operative | 9 | 2020 | 1931 | 0.410 |
Why?
|
| Heart Failure | 29 | 2023 | 11879 | 0.410 |
Why?
|
| Arthroplasty, Replacement | 3 | 2021 | 311 | 0.410 |
Why?
|
| Alcohol Drinking | 10 | 2017 | 4045 | 0.400 |
Why?
|
| Subacute Care | 6 | 2022 | 187 | 0.400 |
Why?
|
| Economics, Hospital | 5 | 2021 | 207 | 0.400 |
Why?
|
| Massachusetts | 40 | 2019 | 8890 | 0.390 |
Why?
|
| Employment | 6 | 2022 | 1110 | 0.390 |
Why?
|
| Medically Uninsured | 6 | 2021 | 838 | 0.380 |
Why?
|
| Malpractice | 8 | 2017 | 561 | 0.380 |
Why?
|
| Razoxane | 2 | 2010 | 43 | 0.380 |
Why?
|
| Hospitalists | 4 | 2022 | 297 | 0.380 |
Why?
|
| Sick Sinus Syndrome | 6 | 2009 | 51 | 0.370 |
Why?
|
| Length of Stay | 15 | 2023 | 6491 | 0.370 |
Why?
|
| Prospective Studies | 81 | 2024 | 54872 | 0.360 |
Why?
|
| Medicare Part D | 3 | 2024 | 355 | 0.350 |
Why?
|
| Electronic Health Records | 18 | 2023 | 4880 | 0.350 |
Why?
|
| Health Status | 12 | 2022 | 4087 | 0.350 |
Why?
|
| Cross-Sectional Studies | 42 | 2024 | 26309 | 0.340 |
Why?
|
| Urinalysis | 3 | 2021 | 369 | 0.340 |
Why?
|
| Temperance | 2 | 2006 | 88 | 0.340 |
Why?
|
| Multivariate Analysis | 37 | 2018 | 12064 | 0.340 |
Why?
|
| Mental Disorders | 10 | 2022 | 6869 | 0.340 |
Why?
|
| Patient Transfer | 5 | 2023 | 789 | 0.340 |
Why?
|
| Risk-Taking | 4 | 2011 | 1022 | 0.340 |
Why?
|
| Health Services Research | 14 | 2018 | 1811 | 0.330 |
Why?
|
| Hospital Costs | 8 | 2019 | 955 | 0.330 |
Why?
|
| Hospitals, Rural | 3 | 2020 | 174 | 0.320 |
Why?
|
| Diffusion of Innovation | 10 | 2016 | 724 | 0.320 |
Why?
|
| Cost Savings | 7 | 2022 | 903 | 0.320 |
Why?
|
| Hospitals, Proprietary | 5 | 2015 | 38 | 0.320 |
Why?
|
| Retrospective Studies | 72 | 2024 | 81657 | 0.320 |
Why?
|
| Guideline Adherence | 10 | 2021 | 2233 | 0.310 |
Why?
|
| Switzerland | 9 | 2020 | 322 | 0.310 |
Why?
|
| Hypertrophy, Left Ventricular | 8 | 2023 | 856 | 0.310 |
Why?
|
| Arkansas | 5 | 2024 | 59 | 0.310 |
Why?
|
| Vitamin D Deficiency | 7 | 2019 | 1349 | 0.310 |
Why?
|
| Diagnosis-Related Groups | 4 | 2021 | 445 | 0.300 |
Why?
|
| Substance Abuse Detection | 3 | 2021 | 301 | 0.300 |
Why?
|
| Follow-Up Studies | 52 | 2024 | 39312 | 0.300 |
Why?
|
| Cohort Studies | 52 | 2023 | 41706 | 0.300 |
Why?
|
| Practice Management, Medical | 5 | 2008 | 191 | 0.300 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 3 | 2024 | 428 | 0.300 |
Why?
|
| Mortality | 10 | 2021 | 2908 | 0.290 |
Why?
|
| Reminder Systems | 3 | 2023 | 389 | 0.290 |
Why?
|
| Delirium | 9 | 2010 | 1698 | 0.290 |
Why?
|
| Double-Blind Method | 26 | 2024 | 12430 | 0.290 |
Why?
|
| Physicians, Primary Care | 4 | 2018 | 622 | 0.290 |
Why?
|
| HIV Infections | 25 | 2024 | 17532 | 0.290 |
Why?
|
| Health Services for the Aged | 3 | 2020 | 264 | 0.290 |
Why?
|
| Exercise Therapy | 5 | 2024 | 935 | 0.290 |
Why?
|
| Delivery of Health Care | 7 | 2024 | 5367 | 0.290 |
Why?
|
| Sibling Relations | 1 | 2007 | 46 | 0.290 |
Why?
|
| Prescription Drugs | 4 | 2022 | 634 | 0.290 |
Why?
|
| Pregnancy Complications | 8 | 2022 | 2971 | 0.280 |
Why?
|
| Home Care Services | 3 | 2022 | 659 | 0.280 |
Why?
|
| Nursing Homes | 4 | 2024 | 1084 | 0.280 |
Why?
|
| Cardiac Pacing, Artificial | 9 | 2006 | 881 | 0.280 |
Why?
|
| Arthroplasty, Replacement, Knee | 4 | 2021 | 1389 | 0.270 |
Why?
|
| Ventricular Function, Left | 12 | 2024 | 3934 | 0.270 |
Why?
|
| Hospitals, Voluntary | 3 | 2014 | 39 | 0.270 |
Why?
|
| Calcifediol | 2 | 2019 | 156 | 0.270 |
Why?
|
| Geriatric Assessment | 8 | 2022 | 1422 | 0.270 |
Why?
|
| Body Composition | 5 | 2018 | 2441 | 0.270 |
Why?
|
| Telephone | 4 | 2023 | 629 | 0.270 |
Why?
|
| Hospitals, Community | 4 | 2023 | 363 | 0.270 |
Why?
|
| Postural Balance | 3 | 2020 | 637 | 0.270 |
Why?
|
| Group Practice | 4 | 2021 | 149 | 0.260 |
Why?
|
| Diet, Mediterranean | 2 | 2024 | 746 | 0.260 |
Why?
|
| Multiple Sclerosis | 20 | 2005 | 3229 | 0.260 |
Why?
|
| Time Factors | 33 | 2024 | 40149 | 0.250 |
Why?
|
| Health Care Reform | 4 | 2017 | 1256 | 0.250 |
Why?
|
| Treatment Outcome | 42 | 2024 | 65286 | 0.250 |
Why?
|
| Substance-Related Disorders | 10 | 2019 | 4421 | 0.250 |
Why?
|
| Medical Records | 2 | 2010 | 1408 | 0.250 |
Why?
|
| Self Report | 3 | 2018 | 3771 | 0.240 |
Why?
|
| Logistic Models | 26 | 2020 | 13276 | 0.240 |
Why?
|
| Hospitals, Urban | 9 | 2014 | 494 | 0.240 |
Why?
|
| Internal Medicine | 5 | 2019 | 1064 | 0.240 |
Why?
|
| Eligibility Determination | 3 | 2023 | 421 | 0.240 |
Why?
|
| Neoplasms | 14 | 2024 | 22350 | 0.240 |
Why?
|
| Young Adult | 43 | 2024 | 59939 | 0.240 |
Why?
|
| Neuropsychological Tests | 5 | 2014 | 7119 | 0.240 |
Why?
|
| Boston | 29 | 2020 | 9346 | 0.240 |
Why?
|
| Child | 67 | 2024 | 80670 | 0.240 |
Why?
|
| Chest Pain | 6 | 2021 | 1101 | 0.240 |
Why?
|
| Insurance, Health | 9 | 2022 | 2520 | 0.240 |
Why?
|
| Ownership | 5 | 2021 | 338 | 0.240 |
Why?
|
| Pacemaker, Artificial | 8 | 2009 | 828 | 0.230 |
Why?
|
| Efficiency, Organizational | 4 | 2015 | 695 | 0.230 |
Why?
|
| Decision Support Systems, Clinical | 5 | 2018 | 1178 | 0.230 |
Why?
|
| Patient Care | 3 | 2022 | 629 | 0.230 |
Why?
|
| Testosterone | 4 | 2024 | 2495 | 0.230 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2020 | 453 | 0.220 |
Why?
|
| Minors | 1 | 2024 | 59 | 0.220 |
Why?
|
| Insurance Carriers | 2 | 2022 | 159 | 0.220 |
Why?
|
| Ventricular Remodeling | 3 | 2024 | 1281 | 0.220 |
Why?
|
| Mass Screening | 8 | 2023 | 5454 | 0.220 |
Why?
|
| Inpatients | 6 | 2022 | 2566 | 0.220 |
Why?
|
| United States Indian Health Service | 2 | 2016 | 31 | 0.220 |
Why?
|
| Data Collection | 12 | 2018 | 3321 | 0.220 |
Why?
|
| Adolescent | 64 | 2024 | 88902 | 0.220 |
Why?
|
| Patient-Centered Care | 5 | 2020 | 1445 | 0.220 |
Why?
|
| Diagnostic Tests, Routine | 3 | 2020 | 788 | 0.220 |
Why?
|
| Ambulatory Care Facilities | 2 | 2022 | 939 | 0.220 |
Why?
|
| Age Factors | 23 | 2020 | 18397 | 0.210 |
Why?
|
| Risk Factors | 58 | 2024 | 74889 | 0.210 |
Why?
|
| Risk Management | 4 | 2017 | 558 | 0.210 |
Why?
|
| Hypogonadism | 2 | 2024 | 802 | 0.210 |
Why?
|
| Academic Medical Centers | 10 | 2023 | 2783 | 0.210 |
Why?
|
| Hypertension | 8 | 2024 | 8616 | 0.210 |
Why?
|
| Cardiomyopathies | 5 | 2024 | 2058 | 0.210 |
Why?
|
| Arthroplasty, Replacement, Hip | 4 | 2021 | 1417 | 0.210 |
Why?
|
| Appointments and Schedules | 3 | 2020 | 442 | 0.210 |
Why?
|
| Health Maintenance Organizations | 6 | 2023 | 656 | 0.210 |
Why?
|
| Attitude of Health Personnel | 9 | 2015 | 3927 | 0.210 |
Why?
|
| Cognition | 6 | 2020 | 7057 | 0.200 |
Why?
|
| Anemia | 2 | 2022 | 1514 | 0.200 |
Why?
|
| Child, Preschool | 49 | 2021 | 42577 | 0.200 |
Why?
|
| Competitive Bidding | 1 | 2022 | 16 | 0.200 |
Why?
|
| Activities of Daily Living | 13 | 2022 | 2429 | 0.200 |
Why?
|
| Cognition Disorders | 4 | 2020 | 3967 | 0.200 |
Why?
|
| Health Status Disparities | 5 | 2021 | 1880 | 0.200 |
Why?
|
| Coronary Restenosis | 4 | 2005 | 396 | 0.200 |
Why?
|
| Echocardiography | 19 | 2020 | 5038 | 0.200 |
Why?
|
| Referral and Consultation | 7 | 2018 | 3618 | 0.190 |
Why?
|
| Incidence | 30 | 2024 | 21527 | 0.190 |
Why?
|
| Dairy Products | 2 | 2016 | 490 | 0.190 |
Why?
|
| Body Mass Index | 13 | 2021 | 13050 | 0.190 |
Why?
|
| Exercise Test | 7 | 2024 | 2188 | 0.190 |
Why?
|
| Registries | 16 | 2024 | 8352 | 0.190 |
Why?
|
| Myocardial Ischemia | 6 | 2021 | 2131 | 0.190 |
Why?
|
| Costs and Cost Analysis | 6 | 2023 | 1667 | 0.190 |
Why?
|
| Texas | 3 | 2020 | 410 | 0.190 |
Why?
|
| Safety Management | 4 | 2015 | 765 | 0.190 |
Why?
|
| Physicians, Family | 6 | 2005 | 348 | 0.190 |
Why?
|
| Indians, North American | 2 | 2018 | 354 | 0.190 |
Why?
|
| Pandemics | 15 | 2024 | 8734 | 0.190 |
Why?
|
| Regression Analysis | 19 | 2021 | 6329 | 0.190 |
Why?
|
| Physician-Patient Relations | 5 | 2015 | 3266 | 0.180 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2005 | 348 | 0.180 |
Why?
|
| Adenoma | 3 | 2019 | 2155 | 0.180 |
Why?
|
| Electronic Prescribing | 2 | 2019 | 115 | 0.180 |
Why?
|
| Health Facility Administrators | 1 | 2021 | 32 | 0.180 |
Why?
|
| Medical Errors | 8 | 2009 | 1260 | 0.180 |
Why?
|
| Schools, Medical | 2 | 2018 | 882 | 0.180 |
Why?
|
| Dance Therapy | 1 | 2020 | 8 | 0.180 |
Why?
|
| Prescriptions | 2 | 2021 | 388 | 0.180 |
Why?
|
| Colorectal Neoplasms | 7 | 2023 | 6965 | 0.180 |
Why?
|
| Parents | 4 | 2020 | 3592 | 0.180 |
Why?
|
| Mass Behavior | 1 | 2000 | 12 | 0.180 |
Why?
|
| Aftercare | 3 | 2023 | 915 | 0.180 |
Why?
|
| Diabetes Mellitus | 7 | 2020 | 5888 | 0.180 |
Why?
|
| Dementia | 3 | 2024 | 2741 | 0.180 |
Why?
|
| Neoplasms, Second Primary | 2 | 2007 | 1062 | 0.180 |
Why?
|
| Patients | 5 | 2023 | 908 | 0.180 |
Why?
|
| Health Communication | 1 | 2023 | 216 | 0.180 |
Why?
|
| Patient Selection | 5 | 2021 | 4252 | 0.170 |
Why?
|
| Cost Control | 3 | 2024 | 627 | 0.170 |
Why?
|
| Longitudinal Studies | 21 | 2020 | 14762 | 0.170 |
Why?
|
| Adipose Tissue | 3 | 2017 | 3317 | 0.170 |
Why?
|
| Health Records, Personal | 2 | 2013 | 126 | 0.170 |
Why?
|
| Unnecessary Procedures | 2 | 2020 | 412 | 0.170 |
Why?
|
| Long-Term Care | 1 | 2024 | 630 | 0.170 |
Why?
|
| Risk | 14 | 2017 | 9602 | 0.170 |
Why?
|
| Analgesics, Opioid | 4 | 2021 | 3837 | 0.170 |
Why?
|
| Heart | 7 | 2021 | 4425 | 0.170 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2021 | 153 | 0.170 |
Why?
|
| Patient Participation | 3 | 2016 | 1445 | 0.170 |
Why?
|
| Drug Therapy, Computer-Assisted | 2 | 2015 | 198 | 0.170 |
Why?
|
| Gift Giving | 1 | 2020 | 76 | 0.170 |
Why?
|
| Delayed Diagnosis | 1 | 2023 | 454 | 0.170 |
Why?
|
| Early Detection of Cancer | 4 | 2023 | 3235 | 0.170 |
Why?
|
| Magnetic Resonance Imaging, Cine | 4 | 2017 | 1089 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 16 | 2021 | 10384 | 0.160 |
Why?
|
| Hodgkin Disease | 1 | 2007 | 1384 | 0.160 |
Why?
|
| Nursing Staff | 1 | 2020 | 113 | 0.160 |
Why?
|
| Office Visits | 3 | 2020 | 593 | 0.160 |
Why?
|
| Health Policy | 5 | 2022 | 2697 | 0.160 |
Why?
|
| Visual Acuity | 4 | 2024 | 2714 | 0.160 |
Why?
|
| Kentucky | 2 | 2016 | 83 | 0.160 |
Why?
|
| Postal Service | 4 | 1992 | 96 | 0.160 |
Why?
|
| Attitude to Health | 4 | 2020 | 2021 | 0.160 |
Why?
|
| Data Interpretation, Statistical | 6 | 2005 | 2694 | 0.160 |
Why?
|
| Predictive Value of Tests | 19 | 2016 | 15425 | 0.160 |
Why?
|
| Anti-Retroviral Agents | 3 | 2024 | 1787 | 0.160 |
Why?
|
| Dancing | 1 | 2020 | 105 | 0.160 |
Why?
|
| Pregnancy | 24 | 2022 | 30236 | 0.160 |
Why?
|
| Hospital Charges | 2 | 2018 | 345 | 0.160 |
Why?
|
| Obesity | 7 | 2020 | 13090 | 0.160 |
Why?
|
| Exercise Tolerance | 1 | 2024 | 845 | 0.160 |
Why?
|
| Troponin T | 3 | 2021 | 786 | 0.160 |
Why?
|
| Physician Incentive Plans | 1 | 2020 | 165 | 0.160 |
Why?
|
| Community Health Planning | 1 | 2019 | 164 | 0.160 |
Why?
|
| Time and Motion Studies | 3 | 2020 | 143 | 0.160 |
Why?
|
| Insurance, Health, Reimbursement | 2 | 2020 | 388 | 0.160 |
Why?
|
| Hospice Care | 3 | 2022 | 678 | 0.160 |
Why?
|
| Community-Institutional Relations | 1 | 2020 | 209 | 0.150 |
Why?
|
| Stress, Psychological | 8 | 2011 | 4526 | 0.150 |
Why?
|
| Statistics as Topic | 6 | 2011 | 2350 | 0.150 |
Why?
|
| Outpatients | 2 | 2023 | 1596 | 0.150 |
Why?
|
| Attitude to Computers | 6 | 2008 | 196 | 0.150 |
Why?
|
| Cocaine | 4 | 1997 | 944 | 0.150 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2019 | 134 | 0.150 |
Why?
|
| Homicide | 2 | 2000 | 294 | 0.150 |
Why?
|
| Stents | 5 | 2013 | 3193 | 0.150 |
Why?
|
| Disability Evaluation | 8 | 2020 | 1828 | 0.150 |
Why?
|
| Risk Assessment | 18 | 2024 | 24299 | 0.150 |
Why?
|
| Resistance Training | 1 | 2020 | 197 | 0.150 |
Why?
|
| Chronic Disease | 10 | 2024 | 9358 | 0.150 |
Why?
|
| Hospital Bed Capacity | 7 | 2017 | 200 | 0.150 |
Why?
|
| Heart Ventricles | 8 | 2017 | 3831 | 0.150 |
Why?
|
| Social Work | 1 | 2019 | 158 | 0.150 |
Why?
|
| Iatrogenic Disease | 4 | 2006 | 551 | 0.150 |
Why?
|
| Ventricular Dysfunction, Left | 7 | 2020 | 2143 | 0.150 |
Why?
|
| Cardiotoxins | 1 | 2017 | 36 | 0.150 |
Why?
|
| Disasters | 1 | 2024 | 521 | 0.150 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 2 | 2012 | 497 | 0.150 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2022 | 452 | 0.150 |
Why?
|
| Body Fluid Compartments | 1 | 2017 | 49 | 0.140 |
Why?
|
| Risk Adjustment | 4 | 2014 | 597 | 0.140 |
Why?
|
| Heptanoic Acids | 3 | 2005 | 344 | 0.140 |
Why?
|
| Sensitivity and Specificity | 14 | 2019 | 14653 | 0.140 |
Why?
|
| Social Conditions | 1 | 2018 | 118 | 0.140 |
Why?
|
| Dietary Fats | 2 | 2016 | 2001 | 0.140 |
Why?
|
| Severity of Illness Index | 15 | 2020 | 15912 | 0.140 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2020 | 2183 | 0.140 |
Why?
|
| Professional-Family Relations | 2 | 2020 | 500 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 12 | 2020 | 10745 | 0.140 |
Why?
|
| Poisson Distribution | 5 | 2020 | 507 | 0.140 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 996 | 0.140 |
Why?
|
| Thyrotropin | 1 | 2020 | 834 | 0.140 |
Why?
|
| Music | 1 | 2020 | 248 | 0.140 |
Why?
|
| Specialization | 3 | 2020 | 779 | 0.140 |
Why?
|
| Behavior Therapy | 2 | 2017 | 886 | 0.140 |
Why?
|
| Genital Neoplasms, Female | 1 | 2022 | 534 | 0.140 |
Why?
|
| Relaxation Therapy | 2 | 2010 | 180 | 0.140 |
Why?
|
| Confidence Intervals | 8 | 2019 | 2921 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 9 | 2018 | 4056 | 0.140 |
Why?
|
| Polypharmacy | 1 | 2019 | 307 | 0.140 |
Why?
|
| Prevalence | 14 | 2024 | 15835 | 0.140 |
Why?
|
| Blood Pressure | 4 | 2020 | 8533 | 0.130 |
Why?
|
| Postoperative Period | 5 | 2020 | 1824 | 0.130 |
Why?
|
| Internationality | 2 | 2019 | 1006 | 0.130 |
Why?
|
| Social Perception | 1 | 2020 | 435 | 0.130 |
Why?
|
| Adiposity | 2 | 2017 | 1892 | 0.130 |
Why?
|
| Continuity of Patient Care | 4 | 2015 | 1077 | 0.130 |
Why?
|
| Receptors, Transferrin | 3 | 2022 | 300 | 0.130 |
Why?
|
| Developed Countries | 1 | 2019 | 453 | 0.130 |
Why?
|
| Clinical Coding | 1 | 2018 | 187 | 0.130 |
Why?
|
| Foreign Medical Graduates | 1 | 2017 | 76 | 0.130 |
Why?
|
| Analysis of Variance | 12 | 2013 | 6214 | 0.130 |
Why?
|
| Pain Measurement | 6 | 2020 | 3576 | 0.130 |
Why?
|
| District of Columbia | 1 | 2016 | 159 | 0.130 |
Why?
|
| Cyclophosphamide | 7 | 2005 | 2234 | 0.130 |
Why?
|
| Interview, Psychological | 2 | 2011 | 810 | 0.130 |
Why?
|
| Mentors | 1 | 2021 | 671 | 0.120 |
Why?
|
| Beverages | 1 | 2021 | 819 | 0.120 |
Why?
|
| Panic Disorder | 1 | 1999 | 613 | 0.120 |
Why?
|
| Opioid-Related Disorders | 2 | 2021 | 2188 | 0.120 |
Why?
|
| Professional Practice | 1 | 2017 | 314 | 0.120 |
Why?
|
| Health Facility Closure | 1 | 2015 | 24 | 0.120 |
Why?
|
| Recovery of Function | 4 | 2019 | 2978 | 0.120 |
Why?
|
| Accreditation | 1 | 2018 | 476 | 0.120 |
Why?
|
| Hemoglobins | 4 | 2022 | 1531 | 0.120 |
Why?
|
| Perinatal Care | 1 | 2017 | 244 | 0.120 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2023 | 949 | 0.120 |
Why?
|
| Critical Care | 4 | 2017 | 2714 | 0.120 |
Why?
|
| Electrocardiography | 9 | 2020 | 6408 | 0.120 |
Why?
|
| Radiation Oncology | 1 | 2021 | 572 | 0.120 |
Why?
|
| Sex Factors | 13 | 2020 | 10619 | 0.120 |
Why?
|
| Cannabis | 2 | 2011 | 447 | 0.120 |
Why?
|
| Body Size | 1 | 2017 | 461 | 0.120 |
Why?
|
| Coronary Vessels | 5 | 2012 | 3115 | 0.120 |
Why?
|
| Benchmarking | 4 | 2010 | 1056 | 0.120 |
Why?
|
| Stroke | 5 | 2024 | 9744 | 0.120 |
Why?
|
| Infant, Newborn | 27 | 2022 | 26387 | 0.120 |
Why?
|
| Angina Pectoris | 5 | 2005 | 956 | 0.120 |
Why?
|
| Clinical Medicine | 1 | 1996 | 145 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 11 | 2019 | 7430 | 0.120 |
Why?
|
| Incidental Findings | 1 | 2019 | 698 | 0.120 |
Why?
|
| Databases, Factual | 11 | 2021 | 8065 | 0.120 |
Why?
|
| Intensive Care Units | 6 | 2021 | 3799 | 0.120 |
Why?
|
| Fractures, Bone | 5 | 2020 | 2043 | 0.120 |
Why?
|
| Colistin | 1 | 2014 | 46 | 0.110 |
Why?
|
| Hospitals, Public | 2 | 2014 | 204 | 0.110 |
Why?
|
| Diltiazem | 1 | 2014 | 132 | 0.110 |
Why?
|
| Infertility | 2 | 2011 | 655 | 0.110 |
Why?
|
| Chief Executive Officers, Hospital | 1 | 2014 | 9 | 0.110 |
Why?
|
| Cardiovascular Diseases | 8 | 2024 | 15652 | 0.110 |
Why?
|
| Survival Rate | 13 | 2021 | 12826 | 0.110 |
Why?
|
| Cause of Death | 7 | 2018 | 3717 | 0.110 |
Why?
|
| Heterozygote | 3 | 2018 | 2795 | 0.110 |
Why?
|
| Infant | 35 | 2020 | 36459 | 0.110 |
Why?
|
| beta-Lactam Resistance | 1 | 2014 | 79 | 0.110 |
Why?
|
| Coronary Artery Disease | 6 | 2020 | 6575 | 0.110 |
Why?
|
| Violence | 1 | 2000 | 931 | 0.110 |
Why?
|
| Calcium, Dietary | 2 | 2014 | 527 | 0.110 |
Why?
|
| Mammary Glands, Human | 1 | 2015 | 201 | 0.110 |
Why?
|
| Adrenocorticotropic Hormone | 7 | 1993 | 618 | 0.110 |
Why?
|
| Evidence-Based Medicine | 4 | 2019 | 3692 | 0.110 |
Why?
|
| Myocardial Contraction | 4 | 2012 | 1516 | 0.110 |
Why?
|
| Heart Transplantation | 7 | 2015 | 3306 | 0.110 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2017 | 1900 | 0.110 |
Why?
|
| Clinical Competence | 5 | 2018 | 4858 | 0.110 |
Why?
|
| Computers | 1 | 2016 | 589 | 0.110 |
Why?
|
| Selection Bias | 1 | 1995 | 359 | 0.110 |
Why?
|
| Linear Models | 9 | 2019 | 5873 | 0.110 |
Why?
|
| Drug Industry | 1 | 2020 | 791 | 0.110 |
Why?
|
| Infection Control | 1 | 2021 | 984 | 0.110 |
Why?
|
| Research Design | 6 | 2015 | 6206 | 0.110 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2017 | 3250 | 0.110 |
Why?
|
| Spouses | 2 | 2006 | 286 | 0.110 |
Why?
|
| Carbapenems | 1 | 2014 | 125 | 0.110 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2016 | 420 | 0.110 |
Why?
|
| Medical Staff, Hospital | 3 | 2012 | 602 | 0.110 |
Why?
|
| Arthritis, Rheumatoid | 5 | 2010 | 3788 | 0.110 |
Why?
|
| Patient Education as Topic | 5 | 2016 | 2334 | 0.110 |
Why?
|
| Pyrroles | 3 | 2005 | 1121 | 0.110 |
Why?
|
| Terminal Care | 3 | 2021 | 1769 | 0.110 |
Why?
|
| Institutionalization | 1 | 2013 | 108 | 0.110 |
Why?
|
| Environment | 1 | 2019 | 1120 | 0.110 |
Why?
|
| Proportional Hazards Models | 12 | 2019 | 12536 | 0.110 |
Why?
|
| Osteoarthritis, Knee | 2 | 2020 | 1251 | 0.110 |
Why?
|
| Mental Health Services | 2 | 2020 | 1728 | 0.110 |
Why?
|
| Mental Health | 4 | 2019 | 3269 | 0.100 |
Why?
|
| Uncompensated Care | 1 | 2013 | 37 | 0.100 |
Why?
|
| Acute Disease | 8 | 2014 | 7240 | 0.100 |
Why?
|
| Internet | 4 | 2020 | 3113 | 0.100 |
Why?
|
| Pediatrics | 4 | 2020 | 3614 | 0.100 |
Why?
|
| Lung Neoplasms | 6 | 2023 | 13489 | 0.100 |
Why?
|
| Health Services Misuse | 3 | 2013 | 245 | 0.100 |
Why?
|
| Public Health | 3 | 2024 | 2680 | 0.100 |
Why?
|
| Hypochondriasis | 1 | 2013 | 93 | 0.100 |
Why?
|
| Medical Oncology | 2 | 2024 | 2340 | 0.100 |
Why?
|
| Income | 8 | 2020 | 1876 | 0.100 |
Why?
|
| Social Support | 2 | 2017 | 2191 | 0.100 |
Why?
|
| Fires | 1 | 2014 | 170 | 0.100 |
Why?
|
| Gonadotropins | 2 | 1993 | 241 | 0.100 |
Why?
|
| Overweight | 3 | 2020 | 2447 | 0.100 |
Why?
|
| Mutation | 8 | 2019 | 30214 | 0.100 |
Why?
|
| Bariatric Surgery | 1 | 2022 | 996 | 0.100 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2014 | 239 | 0.100 |
Why?
|
| Insurance Claim Review | 5 | 2018 | 744 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 1271 | 0.100 |
Why?
|
| Weight Loss | 2 | 2021 | 2712 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2020 | 12246 | 0.100 |
Why?
|
| Breast Neoplasms | 11 | 2020 | 21162 | 0.100 |
Why?
|
| Alzheimer Disease | 2 | 2024 | 8715 | 0.100 |
Why?
|
| Managed Care Programs | 1 | 2017 | 935 | 0.100 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2012 | 65 | 0.100 |
Why?
|
| Case-Control Studies | 15 | 2021 | 22248 | 0.100 |
Why?
|
| Product Labeling | 1 | 2012 | 75 | 0.100 |
Why?
|
| Death | 3 | 2022 | 685 | 0.100 |
Why?
|
| Critical Illness | 3 | 2018 | 2750 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2010 | 678 | 0.100 |
Why?
|
| Myocardium | 5 | 2023 | 4765 | 0.100 |
Why?
|
| Prenatal Care | 6 | 2011 | 1158 | 0.090 |
Why?
|
| Nursing Assessment | 3 | 2010 | 107 | 0.090 |
Why?
|
| Mandatory Reporting | 1 | 2012 | 123 | 0.090 |
Why?
|
| Comorbidity | 7 | 2011 | 10580 | 0.090 |
Why?
|
| International Cooperation | 1 | 2018 | 1434 | 0.090 |
Why?
|
| Medical Audit | 6 | 2012 | 454 | 0.090 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2014 | 263 | 0.090 |
Why?
|
| Colonoscopy | 1 | 2019 | 1409 | 0.090 |
Why?
|
| Calcium Channel Blockers | 1 | 2014 | 687 | 0.090 |
Why?
|
| Socioeconomic Factors | 11 | 2024 | 7841 | 0.090 |
Why?
|
| Maternal Exposure | 2 | 2011 | 1096 | 0.090 |
Why?
|
| Single-Blind Method | 8 | 2017 | 1587 | 0.090 |
Why?
|
| Pyridines | 2 | 2013 | 2888 | 0.090 |
Why?
|
| State Health Plans | 1 | 2013 | 220 | 0.090 |
Why?
|
| Fatty Acids | 2 | 2016 | 1806 | 0.090 |
Why?
|
| Mental Status Schedule | 3 | 2010 | 315 | 0.090 |
Why?
|
| Clinical Alarms | 1 | 2011 | 59 | 0.090 |
Why?
|
| Liver Failure, Acute | 1 | 2012 | 182 | 0.090 |
Why?
|
| Crowding | 1 | 2012 | 142 | 0.090 |
Why?
|
| Dental Care for Aged | 1 | 1990 | 33 | 0.090 |
Why?
|
| Odds Ratio | 13 | 2018 | 9661 | 0.090 |
Why?
|
| Heart Valve Diseases | 1 | 2018 | 1029 | 0.090 |
Why?
|
| Pregnancy, High-Risk | 2 | 2015 | 121 | 0.090 |
Why?
|
| Survival Analysis | 12 | 2017 | 10101 | 0.090 |
Why?
|
| Health Services | 2 | 2006 | 755 | 0.090 |
Why?
|
| Chi-Square Distribution | 8 | 2011 | 3431 | 0.090 |
Why?
|
| Personality | 2 | 2008 | 560 | 0.090 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 1997 | 889 | 0.090 |
Why?
|
| Community Health Services | 2 | 2013 | 659 | 0.090 |
Why?
|
| Bone Diseases | 1 | 2014 | 412 | 0.090 |
Why?
|
| Locomotion | 2 | 1995 | 388 | 0.090 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 4 | 2005 | 551 | 0.090 |
Why?
|
| Nicotinic Agonists | 1 | 2012 | 265 | 0.090 |
Why?
|
| Quinoxalines | 1 | 2012 | 297 | 0.090 |
Why?
|
| Employee Performance Appraisal | 1 | 1990 | 86 | 0.090 |
Why?
|
| Benzazepines | 1 | 2012 | 307 | 0.090 |
Why?
|
| Postoperative Complications | 7 | 2018 | 15831 | 0.090 |
Why?
|
| Workers' Compensation | 1 | 1991 | 150 | 0.090 |
Why?
|
| Central Nervous System Depressants | 1 | 2011 | 163 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 7 | 2003 | 2204 | 0.090 |
Why?
|
| Coronary Disease | 6 | 2012 | 5915 | 0.090 |
Why?
|
| Social Adjustment | 2 | 2007 | 634 | 0.090 |
Why?
|
| Environment Design | 1 | 2011 | 174 | 0.090 |
Why?
|
| Medical Record Linkage | 2 | 2009 | 286 | 0.080 |
Why?
|
| Residence Characteristics | 3 | 2018 | 2116 | 0.080 |
Why?
|
| Mitral Valve | 1 | 2018 | 1473 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 4 | 2013 | 5753 | 0.080 |
Why?
|
| Drinking | 1 | 2011 | 196 | 0.080 |
Why?
|
| Interviews as Topic | 1 | 2017 | 2741 | 0.080 |
Why?
|
| Angioplasty | 1 | 2012 | 355 | 0.080 |
Why?
|
| Heart Rate, Fetal | 1 | 2010 | 77 | 0.080 |
Why?
|
| Pregnancy in Adolescence | 1 | 2011 | 164 | 0.080 |
Why?
|
| Hospices | 2 | 2016 | 245 | 0.080 |
Why?
|
| Ferritins | 2 | 2022 | 601 | 0.080 |
Why?
|
| Cardiovascular Agents | 2 | 2010 | 849 | 0.080 |
Why?
|
| Anticholesteremic Agents | 3 | 2004 | 970 | 0.080 |
Why?
|
| Depressive Disorder, Major | 1 | 2007 | 4810 | 0.080 |
Why?
|
| Exercise | 3 | 2022 | 5945 | 0.080 |
Why?
|
| MEDLINE | 2 | 2006 | 119 | 0.080 |
Why?
|
| Plasmapheresis | 1 | 1990 | 205 | 0.080 |
Why?
|
| Gastrointestinal Diseases | 2 | 1997 | 1203 | 0.080 |
Why?
|
| Hematocrit | 3 | 2000 | 622 | 0.080 |
Why?
|
| Workload | 3 | 2008 | 849 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2021 | 2039 | 0.080 |
Why?
|
| Anthropometry | 6 | 2018 | 1336 | 0.080 |
Why?
|
| California | 5 | 2019 | 1435 | 0.080 |
Why?
|
| Demography | 2 | 2019 | 1641 | 0.080 |
Why?
|
| Diastole | 3 | 2020 | 784 | 0.080 |
Why?
|
| Osteoporosis | 2 | 2011 | 1581 | 0.080 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2009 | 87 | 0.080 |
Why?
|
| Plasma Exchange | 1 | 1989 | 160 | 0.080 |
Why?
|
| Acetaminophen | 1 | 2012 | 549 | 0.080 |
Why?
|
| Reproducibility of Results | 11 | 2022 | 20146 | 0.080 |
Why?
|
| Lower Extremity | 3 | 2020 | 1217 | 0.080 |
Why?
|
| C-Reactive Protein | 4 | 2024 | 3853 | 0.080 |
Why?
|
| Ischemic Attack, Transient | 1 | 2014 | 874 | 0.080 |
Why?
|
| Milk | 1 | 2011 | 436 | 0.070 |
Why?
|
| Physical Fitness | 2 | 2020 | 743 | 0.070 |
Why?
|
| Family Health | 1 | 2013 | 1254 | 0.070 |
Why?
|
| Doxorubicin | 2 | 2010 | 2229 | 0.070 |
Why?
|
| Antirheumatic Agents | 3 | 2010 | 1383 | 0.070 |
Why?
|
| Total Quality Management | 3 | 1999 | 264 | 0.070 |
Why?
|
| Pregnancy Rate | 1 | 2011 | 654 | 0.070 |
Why?
|
| Canada | 4 | 2019 | 2126 | 0.070 |
Why?
|
| HIV-1 | 7 | 2010 | 6948 | 0.070 |
Why?
|
| Platinum Compounds | 1 | 2008 | 94 | 0.070 |
Why?
|
| Homes for the Aged | 2 | 2024 | 273 | 0.070 |
Why?
|
| Nutrition Surveys | 5 | 2018 | 1737 | 0.070 |
Why?
|
| Heterocyclic Compounds | 1 | 2009 | 245 | 0.070 |
Why?
|
| Mind-Body Therapies | 1 | 2011 | 294 | 0.070 |
Why?
|
| Pain, Postoperative | 4 | 2004 | 1768 | 0.070 |
Why?
|
| Ambulatory Care Information Systems | 1 | 2007 | 89 | 0.070 |
Why?
|
| Insurance | 1 | 2009 | 115 | 0.070 |
Why?
|
| Forecasting | 3 | 2017 | 2936 | 0.070 |
Why?
|
| Bradycardia | 2 | 2000 | 304 | 0.070 |
Why?
|
| Travel | 3 | 2023 | 806 | 0.070 |
Why?
|
| Adaptation, Psychological | 4 | 2007 | 2662 | 0.070 |
Why?
|
| Amines | 1 | 2009 | 280 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2010 | 1561 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2023 | 18076 | 0.070 |
Why?
|
| HIV Seropositivity | 3 | 2011 | 962 | 0.070 |
Why?
|
| Cholesterol, LDL | 4 | 2008 | 2392 | 0.070 |
Why?
|
| Models, Biological | 6 | 2017 | 9464 | 0.070 |
Why?
|
| HTLV-I Infections | 2 | 2000 | 104 | 0.070 |
Why?
|
| Zidovudine | 3 | 2000 | 625 | 0.070 |
Why?
|
| Cesarean Section | 1 | 2015 | 1418 | 0.070 |
Why?
|
| Statistics, Nonparametric | 6 | 2018 | 2846 | 0.070 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2007 | 300 | 0.070 |
Why?
|
| Antihypertensive Agents | 2 | 2008 | 2030 | 0.070 |
Why?
|
| Patient Access to Records | 1 | 2007 | 120 | 0.070 |
Why?
|
| Antioxidants | 2 | 2005 | 1671 | 0.070 |
Why?
|
| General Surgery | 1 | 2018 | 1720 | 0.070 |
Why?
|
| Scientific Misconduct | 1 | 2007 | 77 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 2513 | 0.070 |
Why?
|
| Physical Therapy Modalities | 1 | 2010 | 533 | 0.070 |
Why?
|
| Personality Inventory | 2 | 2007 | 1019 | 0.070 |
Why?
|
| Social Isolation | 1 | 2009 | 366 | 0.070 |
Why?
|
| Culture | 1 | 2010 | 622 | 0.070 |
Why?
|
| Prognosis | 13 | 2017 | 29959 | 0.070 |
Why?
|
| Europe | 2 | 2024 | 3430 | 0.070 |
Why?
|
| Calcium | 3 | 2012 | 5783 | 0.070 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2020 | 497 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2014 | 2270 | 0.060 |
Why?
|
| Combined Modality Therapy | 6 | 2021 | 8540 | 0.060 |
Why?
|
| Waiting Lists | 1 | 2011 | 779 | 0.060 |
Why?
|
| Cardiology | 3 | 2009 | 1701 | 0.060 |
Why?
|
| Medical History Taking | 3 | 2019 | 779 | 0.060 |
Why?
|
| Communication | 4 | 2019 | 3905 | 0.060 |
Why?
|
| Pilot Projects | 7 | 2018 | 8728 | 0.060 |
Why?
|
| Seasons | 2 | 2013 | 1519 | 0.060 |
Why?
|
| Growth | 2 | 2001 | 365 | 0.060 |
Why?
|
| Meat | 1 | 2009 | 588 | 0.060 |
Why?
|
| Vascular Diseases | 1 | 2014 | 1161 | 0.060 |
Why?
|
| Weather | 1 | 2007 | 234 | 0.060 |
Why?
|
| Receptor, Bradykinin B1 | 1 | 2005 | 12 | 0.060 |
Why?
|
| Hospital-Patient Relations | 1 | 2005 | 17 | 0.060 |
Why?
|
| Program Evaluation | 3 | 2020 | 2504 | 0.060 |
Why?
|
| Job Satisfaction | 1 | 2009 | 548 | 0.060 |
Why?
|
| Health Promotion | 1 | 2017 | 2209 | 0.060 |
Why?
|
| Geography | 2 | 2018 | 651 | 0.060 |
Why?
|
| Methylprednisolone | 2 | 1999 | 387 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 1730 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 4903 | 0.060 |
Why?
|
| Occupational Health | 1 | 1992 | 812 | 0.060 |
Why?
|
| Drug Therapy, Combination | 7 | 2013 | 6306 | 0.060 |
Why?
|
| Fecal Incontinence | 1 | 2008 | 246 | 0.060 |
Why?
|
| Drug Implants | 1 | 2005 | 230 | 0.060 |
Why?
|
| Fever | 1 | 2012 | 1607 | 0.060 |
Why?
|
| Caregivers | 1 | 2017 | 2303 | 0.060 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2008 | 271 | 0.060 |
Why?
|
| Medicine | 1 | 2013 | 944 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 9244 | 0.060 |
Why?
|
| Infectious Disease Transmission, Vertical | 4 | 2011 | 1353 | 0.060 |
Why?
|
| Family Relations | 1 | 2007 | 318 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2010 | 1111 | 0.060 |
Why?
|
| Heart Diseases | 4 | 2004 | 2817 | 0.060 |
Why?
|
| Ethanol | 1 | 2011 | 1326 | 0.060 |
Why?
|
| Intelligence | 1 | 2010 | 925 | 0.060 |
Why?
|
| Mood Disorders | 2 | 2005 | 1127 | 0.060 |
Why?
|
| Communication Barriers | 2 | 2017 | 418 | 0.060 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2005 | 1456 | 0.060 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2004 | 38 | 0.060 |
Why?
|
| Morbidity | 5 | 2011 | 1754 | 0.060 |
Why?
|
| Triage | 3 | 2011 | 995 | 0.060 |
Why?
|
| Hypnotics and Sedatives | 1 | 2012 | 1193 | 0.060 |
Why?
|
| Ascorbic Acid | 2 | 2005 | 658 | 0.060 |
Why?
|
| Infusion Pumps | 1 | 2005 | 163 | 0.060 |
Why?
|
| Physician's Role | 4 | 2003 | 925 | 0.060 |
Why?
|
| Health Personnel | 5 | 2018 | 3384 | 0.060 |
Why?
|
| Aspirin | 2 | 2013 | 3134 | 0.060 |
Why?
|
| Kidney | 1 | 2019 | 7073 | 0.060 |
Why?
|
| Models, Economic | 3 | 2016 | 719 | 0.060 |
Why?
|
| Syncope | 2 | 2004 | 431 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2306 | 0.050 |
Why?
|
| Acetates | 1 | 2005 | 314 | 0.050 |
Why?
|
| Terminally Ill | 2 | 2021 | 240 | 0.050 |
Why?
|
| Psychomotor Performance | 3 | 2020 | 1885 | 0.050 |
Why?
|
| Preventive Health Services | 2 | 2017 | 570 | 0.050 |
Why?
|
| Workflow | 1 | 2008 | 859 | 0.050 |
Why?
|
| Iron | 2 | 2022 | 1812 | 0.050 |
Why?
|
| Atrial Fibrillation | 5 | 2009 | 5182 | 0.050 |
Why?
|
| Sex Ratio | 1 | 2004 | 107 | 0.050 |
Why?
|
| HIV | 1 | 2011 | 1588 | 0.050 |
Why?
|
| Intubation | 1 | 2024 | 140 | 0.050 |
Why?
|
| Anti-HIV Agents | 4 | 2024 | 4561 | 0.050 |
Why?
|
| Urinary Incontinence | 1 | 2008 | 490 | 0.050 |
Why?
|
| Interferon-beta | 1 | 2005 | 348 | 0.050 |
Why?
|
| Maternal Behavior | 1 | 2006 | 307 | 0.050 |
Why?
|
| Androstadienes | 1 | 2005 | 348 | 0.050 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 3 | 2000 | 253 | 0.050 |
Why?
|
| Sexual Behavior | 1 | 1993 | 2193 | 0.050 |
Why?
|
| Transforming Growth Factors | 1 | 2023 | 76 | 0.050 |
Why?
|
| Chromosomes, Human, X | 1 | 2005 | 319 | 0.050 |
Why?
|
| Health Status Indicators | 3 | 2001 | 968 | 0.050 |
Why?
|
| Computer Literacy | 3 | 2008 | 44 | 0.050 |
Why?
|
| Fathers | 1 | 2006 | 377 | 0.050 |
Why?
|
| Disease Progression | 10 | 2019 | 13642 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 2 | 2004 | 2730 | 0.050 |
Why?
|
| Insurance Claim Reporting | 2 | 2001 | 166 | 0.050 |
Why?
|
| Vitamin E | 2 | 2005 | 872 | 0.050 |
Why?
|
| Myocarditis | 2 | 2011 | 802 | 0.050 |
Why?
|
| Needs Assessment | 2 | 2022 | 1140 | 0.050 |
Why?
|
| Smoking | 4 | 2004 | 9077 | 0.050 |
Why?
|
| Surgical Sponges | 1 | 2003 | 40 | 0.050 |
Why?
|
| Fertilization in Vitro | 1 | 2011 | 1301 | 0.050 |
Why?
|
| Cardiotonic Agents | 3 | 2011 | 541 | 0.050 |
Why?
|
| Coronary Angiography | 4 | 2005 | 4525 | 0.050 |
Why?
|
| Policy Making | 2 | 2018 | 546 | 0.050 |
Why?
|
| Diagnosis, Differential | 3 | 2011 | 12985 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3110 | 0.050 |
Why?
|
| Mobility Limitation | 2 | 2017 | 409 | 0.050 |
Why?
|
| Bone Density Conservation Agents | 1 | 2010 | 791 | 0.050 |
Why?
|
| Educational Status | 4 | 2015 | 2510 | 0.050 |
Why?
|
| Arrhythmia, Sinus | 1 | 2002 | 48 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3232 | 0.050 |
Why?
|
| Bibliometrics | 1 | 2006 | 355 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 6 | 2020 | 5536 | 0.050 |
Why?
|
| Durable Medical Equipment | 1 | 2022 | 23 | 0.050 |
Why?
|
| Heart Rate | 6 | 2012 | 4207 | 0.050 |
Why?
|
| Narcotics | 3 | 1997 | 332 | 0.050 |
Why?
|
| Lovastatin | 1 | 2002 | 114 | 0.050 |
Why?
|
| Self Concept | 1 | 2008 | 1040 | 0.050 |
Why?
|
| Age Distribution | 3 | 2016 | 2869 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2010 | 2257 | 0.050 |
Why?
|
| Employee Discipline | 2 | 1992 | 8 | 0.050 |
Why?
|
| Dopamine Antagonists | 1 | 2002 | 279 | 0.050 |
Why?
|
| Pelvic Bones | 1 | 2004 | 274 | 0.050 |
Why?
|
| Hypercholesterolemia | 2 | 2001 | 1145 | 0.050 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2004 | 287 | 0.050 |
Why?
|
| Term Birth | 1 | 2022 | 140 | 0.050 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 2 | 2018 | 91 | 0.050 |
Why?
|
| Quinazolines | 1 | 2008 | 1367 | 0.050 |
Why?
|
| Body Weight | 3 | 2017 | 4626 | 0.050 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2002 | 148 | 0.050 |
Why?
|
| Propensity Score | 2 | 2020 | 1972 | 0.050 |
Why?
|
| Bupivacaine | 1 | 2004 | 414 | 0.050 |
Why?
|
| Cultural Diversity | 1 | 2005 | 370 | 0.050 |
Why?
|
| Sex Reassignment Surgery | 1 | 2024 | 164 | 0.050 |
Why?
|
| Subtilisins | 1 | 2021 | 80 | 0.050 |
Why?
|
| Parenting | 1 | 2007 | 708 | 0.050 |
Why?
|
| Survivors | 2 | 2010 | 2379 | 0.050 |
Why?
|
| Goals | 1 | 2006 | 717 | 0.050 |
Why?
|
| Body Height | 2 | 2000 | 1562 | 0.050 |
Why?
|
| Failure to Thrive | 1 | 2001 | 139 | 0.050 |
Why?
|
| Health Surveys | 4 | 2011 | 4055 | 0.050 |
Why?
|
| New Jersey | 4 | 2002 | 296 | 0.050 |
Why?
|
| Defibrillators, Implantable | 1 | 2010 | 1499 | 0.050 |
Why?
|
| Personnel Turnover | 2 | 1992 | 89 | 0.050 |
Why?
|
| Cataract Extraction | 2 | 1995 | 464 | 0.040 |
Why?
|
| Choice Behavior | 2 | 2006 | 846 | 0.040 |
Why?
|
| New England | 4 | 2012 | 1058 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2014 | 3001 | 0.040 |
Why?
|
| Pharmacists | 1 | 2023 | 261 | 0.040 |
Why?
|
| United States Public Health Service | 1 | 2020 | 31 | 0.040 |
Why?
|
| Private Practice | 1 | 2021 | 154 | 0.040 |
Why?
|
| Surgical Instruments | 1 | 2003 | 379 | 0.040 |
Why?
|
| Monitoring, Ambulatory | 1 | 2003 | 357 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2005 | 996 | 0.040 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2005 | 572 | 0.040 |
Why?
|
| Ventilators, Mechanical | 1 | 2022 | 292 | 0.040 |
Why?
|
| Utah | 4 | 2000 | 130 | 0.040 |
Why?
|
| Immunosuppressive Agents | 2 | 2005 | 4215 | 0.040 |
Why?
|
| Sex Distribution | 3 | 2013 | 2274 | 0.040 |
Why?
|
| Urban Health Services | 1 | 2001 | 176 | 0.040 |
Why?
|
| Colorado | 4 | 2000 | 167 | 0.040 |
Why?
|
| Legislation, Hospital | 1 | 2019 | 12 | 0.040 |
Why?
|
| Absenteeism | 2 | 1992 | 247 | 0.040 |
Why?
|
| Quinolines | 1 | 2005 | 769 | 0.040 |
Why?
|
| Accidents, Occupational | 2 | 1992 | 251 | 0.040 |
Why?
|
| Cycloheximide | 1 | 1999 | 340 | 0.040 |
Why?
|
| Professional Practice Location | 2 | 1996 | 57 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 1659 | 0.040 |
Why?
|
| Women's Health Services | 1 | 2000 | 87 | 0.040 |
Why?
|
| Life Style | 3 | 2021 | 3926 | 0.040 |
Why?
|
| Volition | 1 | 2019 | 61 | 0.040 |
Why?
|
| Trust | 1 | 2004 | 532 | 0.040 |
Why?
|
| Organizational Culture | 3 | 2008 | 513 | 0.040 |
Why?
|
| Self-Help Groups | 1 | 2000 | 194 | 0.040 |
Why?
|
| Pravastatin | 1 | 2001 | 391 | 0.040 |
Why?
|
| Pain | 3 | 2019 | 5098 | 0.040 |
Why?
|
| Periodicity | 1 | 2000 | 347 | 0.040 |
Why?
|
| Fees and Charges | 2 | 2016 | 189 | 0.040 |
Why?
|
| Marketing | 1 | 2021 | 225 | 0.040 |
Why?
|
| Hand Strength | 1 | 2022 | 466 | 0.040 |
Why?
|
| Marriage | 2 | 1993 | 351 | 0.040 |
Why?
|
| Infant Mortality | 1 | 2004 | 751 | 0.040 |
Why?
|
| Nutritional Status | 2 | 1997 | 1621 | 0.040 |
Why?
|
| Prolactin | 3 | 2002 | 628 | 0.040 |
Why?
|
| HIV Protease Inhibitors | 1 | 2001 | 430 | 0.040 |
Why?
|
| Hospital Departments | 2 | 2012 | 134 | 0.040 |
Why?
|
| Mental Recall | 2 | 2018 | 1218 | 0.040 |
Why?
|
| Pancreatitis | 2 | 1998 | 1087 | 0.040 |
Why?
|
| Hotlines | 1 | 2018 | 55 | 0.040 |
Why?
|
| Neoplasm Staging | 3 | 2021 | 11218 | 0.040 |
Why?
|
| Foreign Bodies | 1 | 2003 | 403 | 0.040 |
Why?
|
| Language | 2 | 2017 | 1550 | 0.040 |
Why?
|
| New York | 3 | 2012 | 879 | 0.040 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2000 | 174 | 0.040 |
Why?
|
| Waist-Hip Ratio | 2 | 2010 | 521 | 0.040 |
Why?
|
| Health Facilities | 1 | 2023 | 578 | 0.040 |
Why?
|
| Equipment Design | 5 | 2006 | 3488 | 0.040 |
Why?
|
| Safety | 2 | 2014 | 1157 | 0.040 |
Why?
|
| Infant, Premature, Diseases | 1 | 2004 | 712 | 0.040 |
Why?
|
| Drug Hypersensitivity | 2 | 2018 | 903 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2010 | 2505 | 0.040 |
Why?
|
| Papillary Muscles | 1 | 2018 | 192 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2014 | 7475 | 0.040 |
Why?
|
| Carrier Proteins | 3 | 2014 | 4926 | 0.040 |
Why?
|
| Phenotype | 4 | 2019 | 16722 | 0.040 |
Why?
|
| Anesthetics, Local | 1 | 2004 | 1005 | 0.040 |
Why?
|
| Probability | 3 | 2011 | 2476 | 0.040 |
Why?
|
| Troponin I | 2 | 2014 | 659 | 0.040 |
Why?
|
| Sirolimus | 1 | 2005 | 1540 | 0.040 |
Why?
|
| Skinfold Thickness | 1 | 2017 | 164 | 0.040 |
Why?
|
| Hypolipidemic Agents | 1 | 2002 | 609 | 0.040 |
Why?
|
| Genotype | 4 | 2017 | 13036 | 0.040 |
Why?
|
| Fees, Medical | 1 | 2018 | 111 | 0.040 |
Why?
|
| Pets | 1 | 2017 | 46 | 0.040 |
Why?
|
| Depressive Disorder | 4 | 2005 | 3715 | 0.040 |
Why?
|
| Denmark | 1 | 2019 | 777 | 0.040 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2005 | 1250 | 0.040 |
Why?
|
| Laboratories | 1 | 2021 | 463 | 0.040 |
Why?
|
| State Government | 1 | 2020 | 388 | 0.030 |
Why?
|
| Data Display | 1 | 1997 | 174 | 0.030 |
Why?
|
| HIV Core Protein p24 | 1 | 1997 | 245 | 0.030 |
Why?
|
| Weight Gain | 2 | 2000 | 2356 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 1999 | 588 | 0.030 |
Why?
|
| Inservice Training | 1 | 2019 | 374 | 0.030 |
Why?
|
| Longevity | 2 | 2020 | 1083 | 0.030 |
Why?
|
| Organizational Affiliation | 1 | 2016 | 34 | 0.030 |
Why?
|
| Psychotherapy, Group | 1 | 2000 | 417 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 2 | 2019 | 2232 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2018 | 1514 | 0.030 |
Why?
|
| Heart Defects, Congenital | 3 | 2003 | 4712 | 0.030 |
Why?
|
| Duodenal Diseases | 1 | 1997 | 101 | 0.030 |
Why?
|
| Family Practice | 2 | 1996 | 508 | 0.030 |
Why?
|
| Community Health Centers | 3 | 2009 | 469 | 0.030 |
Why?
|
| Health Behavior | 2 | 2006 | 2649 | 0.030 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 1998 | 353 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 1999 | 561 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2005 | 1895 | 0.030 |
Why?
|
| Professional Role | 1 | 2019 | 314 | 0.030 |
Why?
|
| Indiana | 1 | 2016 | 93 | 0.030 |
Why?
|
| Matched-Pair Analysis | 2 | 2013 | 285 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2016 | 36570 | 0.030 |
Why?
|
| Absorptiometry, Photon | 2 | 2017 | 1707 | 0.030 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1999 | 538 | 0.030 |
Why?
|
| Social Behavior | 1 | 2003 | 1147 | 0.030 |
Why?
|
| Esophageal Diseases | 1 | 1997 | 167 | 0.030 |
Why?
|
| Hospitals, Veterans | 1 | 2018 | 395 | 0.030 |
Why?
|
| Depression | 3 | 2005 | 8225 | 0.030 |
Why?
|
| Plants | 1 | 2017 | 332 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2020 | 639 | 0.030 |
Why?
|
| Prospective Payment System | 1 | 2017 | 134 | 0.030 |
Why?
|
| Osteoarthritis | 1 | 2004 | 1072 | 0.030 |
Why?
|
| Stomach Diseases | 1 | 1997 | 134 | 0.030 |
Why?
|
| Disabled Persons | 4 | 2016 | 1209 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2002 | 1740 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2003 | 1126 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1999 | 1131 | 0.030 |
Why?
|
| Monocytes | 1 | 2005 | 2599 | 0.030 |
Why?
|
| Brazil | 1 | 2019 | 1250 | 0.030 |
Why?
|
| Memory | 2 | 2019 | 2192 | 0.030 |
Why?
|
| Community-Based Participatory Research | 1 | 2017 | 223 | 0.030 |
Why?
|
| Anxiety Disorders | 3 | 2005 | 2743 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2017 | 228 | 0.030 |
Why?
|
| Transportation | 1 | 2017 | 216 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2000 | 2537 | 0.030 |
Why?
|
| Recurrence | 6 | 2010 | 8507 | 0.030 |
Why?
|
| Personality Development | 1 | 1996 | 241 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2018 | 751 | 0.030 |
Why?
|
| Conflict of Interest | 1 | 2020 | 556 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 1996 | 0.030 |
Why?
|
| Periodicals as Topic | 1 | 2006 | 1463 | 0.030 |
Why?
|
| Sampling Studies | 2 | 1999 | 614 | 0.030 |
Why?
|
| Financial Management, Hospital | 1 | 2015 | 70 | 0.030 |
Why?
|
| Collagen | 2 | 2013 | 2635 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2003 | 1567 | 0.030 |
Why?
|
| Information Systems | 1 | 2017 | 400 | 0.030 |
Why?
|
| Oxygen | 2 | 2022 | 4252 | 0.030 |
Why?
|
| Cholesterol | 1 | 2024 | 2904 | 0.030 |
Why?
|
| Immunity | 1 | 2020 | 1002 | 0.030 |
Why?
|
| Myelin Sheath | 2 | 1996 | 650 | 0.030 |
Why?
|
| Infertility, Female | 1 | 2000 | 763 | 0.030 |
Why?
|
| Leadership | 2 | 1996 | 1394 | 0.030 |
Why?
|
| Bone Density | 2 | 2004 | 3491 | 0.030 |
Why?
|
| Nutrition Disorders | 2 | 1994 | 203 | 0.030 |
Why?
|
| Nephrology | 1 | 2018 | 270 | 0.030 |
Why?
|
| Aging | 2 | 2022 | 8728 | 0.030 |
Why?
|
| Administration, Oral | 4 | 2009 | 4019 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2000 | 1814 | 0.030 |
Why?
|
| Mammography | 1 | 2005 | 2429 | 0.030 |
Why?
|
| Legislation as Topic | 1 | 2014 | 76 | 0.030 |
Why?
|
| Cholinergic Antagonists | 1 | 1994 | 165 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2024 | 3226 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2017 | 934 | 0.030 |
Why?
|
| Drug Prescriptions | 1 | 2023 | 1663 | 0.030 |
Why?
|
| Administrative Personnel | 1 | 2015 | 185 | 0.030 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2014 | 190 | 0.030 |
Why?
|
| Spondylitis | 1 | 1993 | 20 | 0.030 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1998 | 575 | 0.030 |
Why?
|
| Observer Variation | 4 | 2006 | 2614 | 0.030 |
Why?
|
| Analgesia | 3 | 1998 | 461 | 0.030 |
Why?
|
| Pancreas | 1 | 2000 | 1698 | 0.030 |
Why?
|
| Triamcinolone | 1 | 1993 | 68 | 0.030 |
Why?
|
| Disease Management | 2 | 2016 | 2533 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 2009 | 392 | 0.030 |
Why?
|
| Attention | 2 | 2009 | 2413 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2004 | 2038 | 0.030 |
Why?
|
| Diarrhea | 1 | 2000 | 1317 | 0.030 |
Why?
|
| Feasibility Studies | 4 | 2013 | 5306 | 0.030 |
Why?
|
| Spinal Nerve Roots | 1 | 1993 | 122 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 3803 | 0.030 |
Why?
|
| Medication Adherence | 2 | 2016 | 2190 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2019 | 1497 | 0.030 |
Why?
|
| Physicians, Women | 2 | 2017 | 516 | 0.030 |
Why?
|
| Reaction Time | 1 | 2019 | 2085 | 0.030 |
Why?
|
| Personnel, Hospital | 1 | 2015 | 285 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2008 | 6020 | 0.030 |
Why?
|
| Urban Population | 1 | 2020 | 2040 | 0.030 |
Why?
|
| Immunologic Techniques | 1 | 1992 | 212 | 0.030 |
Why?
|
| Arousal | 1 | 1998 | 1174 | 0.030 |
Why?
|
| Parent-Child Relations | 1 | 2017 | 772 | 0.030 |
Why?
|
| Parity | 1 | 2015 | 931 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 1996 | 433 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2000 | 2764 | 0.020 |
Why?
|
| Gene Expression | 1 | 2005 | 7585 | 0.020 |
Why?
|
| Growth Disorders | 3 | 2010 | 634 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 1995 | 853 | 0.020 |
Why?
|
| Benzodiazepines | 2 | 1997 | 1137 | 0.020 |
Why?
|
| Psychometrics | 2 | 2020 | 3060 | 0.020 |
Why?
|
| Self-Assessment | 3 | 2001 | 400 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2000 | 1008 | 0.020 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 1997 | 621 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 935 | 0.020 |
Why?
|
| Clinical Trials as Topic | 4 | 2005 | 8045 | 0.020 |
Why?
|
| Anxiety | 2 | 2005 | 4668 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 1998 | 1319 | 0.020 |
Why?
|
| Immune Tolerance | 3 | 1996 | 2328 | 0.020 |
Why?
|
| Rural Health | 1 | 1993 | 302 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 1999 | 1015 | 0.020 |
Why?
|
| Interprofessional Relations | 2 | 2015 | 998 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 13644 | 0.020 |
Why?
|
| Government Regulation | 1 | 2016 | 525 | 0.020 |
Why?
|
| Ultrasonography | 4 | 2010 | 5990 | 0.020 |
Why?
|
| Decision Making | 3 | 2012 | 3951 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2007 | 3633 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 2 | 2005 | 565 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2013 | 6514 | 0.020 |
Why?
|
| Models, Econometric | 1 | 1992 | 215 | 0.020 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2013 | 291 | 0.020 |
Why?
|
| Dentures | 1 | 1990 | 12 | 0.020 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2018 | 1065 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 4424 | 0.020 |
Why?
|
| Dental Staff | 1 | 1990 | 14 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 418 | 0.020 |
Why?
|
| Cost Allocation | 1 | 1991 | 48 | 0.020 |
Why?
|
| Assisted Circulation | 1 | 2011 | 99 | 0.020 |
Why?
|
| Injections, Intramuscular | 2 | 1989 | 551 | 0.020 |
Why?
|
| Motivation | 1 | 2021 | 2020 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1995 | 668 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2008 | 5389 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2015 | 1419 | 0.020 |
Why?
|
| Random Allocation | 1 | 1995 | 2394 | 0.020 |
Why?
|
| Radiculopathy | 1 | 1993 | 202 | 0.020 |
Why?
|
| Leukocyte Count | 2 | 1994 | 1606 | 0.020 |
Why?
|
| Nursing Diagnosis | 1 | 2010 | 16 | 0.020 |
Why?
|
| Biometry | 1 | 1994 | 571 | 0.020 |
Why?
|
| Pneumonectomy | 1 | 1997 | 1147 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 1 | 1995 | 870 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1992 | 731 | 0.020 |
Why?
|
| Malabsorption Syndromes | 1 | 1991 | 135 | 0.020 |
Why?
|
| San Francisco | 1 | 1990 | 166 | 0.020 |
Why?
|
| Internship and Residency | 2 | 2003 | 5943 | 0.020 |
Why?
|
| Fetal Monitoring | 1 | 2010 | 69 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 1999 | 2158 | 0.020 |
Why?
|
| Speech Recognition Software | 1 | 2010 | 74 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 1992 | 828 | 0.020 |
Why?
|
| Carbohydrate Metabolism | 1 | 1991 | 261 | 0.020 |
Why?
|
| Carrier State | 1 | 1994 | 530 | 0.020 |
Why?
|
| Coronary Circulation | 2 | 2003 | 1602 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2013 | 823 | 0.020 |
Why?
|
| Biological Assay | 1 | 1992 | 626 | 0.020 |
Why?
|
| Role | 1 | 1990 | 176 | 0.020 |
Why?
|
| Premenopause | 1 | 2014 | 1039 | 0.020 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2011 | 216 | 0.020 |
Why?
|
| Hepatitis C | 1 | 2000 | 1595 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2012 | 371 | 0.020 |
Why?
|
| Ventricular Myosins | 1 | 2009 | 65 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2000 | 5502 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 2007 | 0.020 |
Why?
|
| Puerto Rico | 1 | 2010 | 380 | 0.020 |
Why?
|
| Occupations | 1 | 1992 | 516 | 0.020 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 1990 | 109 | 0.020 |
Why?
|
| Medically Underserved Area | 1 | 2011 | 268 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2002 | 3078 | 0.020 |
Why?
|
| Mathematics | 1 | 1990 | 696 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 1994 | 960 | 0.020 |
Why?
|
| Tropomyosin | 1 | 2009 | 105 | 0.020 |
Why?
|
| Stochastic Processes | 1 | 1990 | 359 | 0.020 |
Why?
|
| Vaccination | 1 | 2021 | 3435 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2001 | 2903 | 0.020 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2010 | 325 | 0.020 |
Why?
|
| Algorithms | 5 | 2013 | 14073 | 0.020 |
Why?
|
| Housing | 1 | 2014 | 683 | 0.020 |
Why?
|
| Cholesterol, HDL | 2 | 2008 | 1814 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1997 | 1390 | 0.020 |
Why?
|
| Psychology | 1 | 2010 | 353 | 0.020 |
Why?
|
| Drug Tolerance | 2 | 2006 | 365 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2013 | 2763 | 0.020 |
Why?
|
| RNA, Viral | 1 | 1997 | 2867 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2003 | 2884 | 0.020 |
Why?
|
| Reproduction | 1 | 1993 | 645 | 0.020 |
Why?
|
| Hospitals, Group Practice | 1 | 2008 | 3 | 0.020 |
Why?
|
| Autoantigens | 1 | 1993 | 890 | 0.020 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1992 | 706 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2001 | 2586 | 0.020 |
Why?
|
| Uganda | 1 | 1993 | 1353 | 0.020 |
Why?
|
| Attitude | 1 | 1993 | 768 | 0.020 |
Why?
|
| Social Class | 2 | 2011 | 2007 | 0.020 |
Why?
|
| E-Selectin | 1 | 2010 | 576 | 0.020 |
Why?
|
| Obstetrics | 1 | 1995 | 679 | 0.020 |
Why?
|
| Hospital Bed Capacity, 500 and over | 2 | 1998 | 113 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 1999 | 3440 | 0.020 |
Why?
|
| Cross Infection | 1 | 1997 | 1427 | 0.020 |
Why?
|
| Standard of Care | 1 | 2012 | 569 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2010 | 605 | 0.020 |
Why?
|
| Blood | 1 | 1990 | 598 | 0.020 |
Why?
|
| P-Selectin | 1 | 2010 | 598 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2010 | 692 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 6066 | 0.020 |
Why?
|
| APACHE | 2 | 1998 | 268 | 0.020 |
Why?
|
| Triglycerides | 2 | 2008 | 2441 | 0.020 |
Why?
|
| Health Care Coalitions | 1 | 2007 | 36 | 0.020 |
Why?
|
| Pulmonary Veins | 1 | 1993 | 759 | 0.020 |
Why?
|
| Reference Values | 2 | 2005 | 4914 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2022 | 4544 | 0.020 |
Why?
|
| Psychotic Disorders | 1 | 2002 | 3275 | 0.020 |
Why?
|
| Men's Health | 1 | 2007 | 75 | 0.020 |
Why?
|
| Fentanyl | 1 | 1990 | 451 | 0.020 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2008 | 240 | 0.020 |
Why?
|
| Aggression | 1 | 2012 | 748 | 0.020 |
Why?
|
| Fibrinogen | 1 | 2010 | 893 | 0.020 |
Why?
|
| Systole | 1 | 2009 | 935 | 0.020 |
Why?
|
| Social Facilitation | 1 | 2006 | 31 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 1993 | 978 | 0.020 |
Why?
|
| Cooking | 1 | 2009 | 327 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2010 | 6853 | 0.020 |
Why?
|
| Dipeptidyl Peptidase 4 | 2 | 2000 | 93 | 0.020 |
Why?
|
| Abdominal Fat | 1 | 2008 | 217 | 0.020 |
Why?
|
| Patient Care Management | 1 | 2009 | 302 | 0.020 |
Why?
|
| Uncertainty | 1 | 2011 | 765 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 11876 | 0.020 |
Why?
|
| Radiography | 2 | 2013 | 6968 | 0.020 |
Why?
|
| Asthma | 1 | 2005 | 6266 | 0.020 |
Why?
|
| Child Health Services | 1 | 2011 | 645 | 0.020 |
Why?
|
| Acetylation | 1 | 2009 | 1055 | 0.020 |
Why?
|
| Electronic Mail | 1 | 2007 | 215 | 0.020 |
Why?
|
| Nursing Staff, Hospital | 1 | 2009 | 350 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 2078 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2005 | 4410 | 0.020 |
Why?
|
| Elastic Tissue | 1 | 2005 | 65 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 1991 | 1251 | 0.020 |
Why?
|
| Sexual Partners | 1 | 1990 | 804 | 0.020 |
Why?
|
| SEER Program | 2 | 2001 | 1444 | 0.020 |
Why?
|
| Manifest Anxiety Scale | 1 | 2005 | 7 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2010 | 811 | 0.020 |
Why?
|
| Gestational Age | 2 | 2005 | 3617 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2008 | 638 | 0.020 |
Why?
|
| Sleep Stages | 2 | 1996 | 705 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2009 | 898 | 0.020 |
Why?
|
| Habits | 1 | 2006 | 148 | 0.020 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1990 | 587 | 0.020 |
Why?
|
| Bangladesh | 2 | 2000 | 745 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 11094 | 0.010 |
Why?
|
| Nurse-Patient Relations | 1 | 2005 | 101 | 0.010 |
Why?
|
| Endometriosis | 1 | 1993 | 868 | 0.010 |
Why?
|
| Sinoatrial Node | 1 | 2005 | 99 | 0.010 |
Why?
|
| Atrioventricular Node | 1 | 2005 | 180 | 0.010 |
Why?
|
| Education | 1 | 1987 | 531 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1990 | 1733 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 4114 | 0.010 |
Why?
|
| Musculoskeletal Physiological Phenomena | 1 | 2004 | 31 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1987 | 642 | 0.010 |
Why?
|
| Affect | 2 | 2009 | 1494 | 0.010 |
Why?
|
| Vasomotor System | 1 | 2005 | 208 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2015 | 2594 | 0.010 |
Why?
|
| Sulfides | 1 | 2005 | 171 | 0.010 |
Why?
|
| Gender Identity | 1 | 1990 | 767 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 2005 | 433 | 0.010 |
Why?
|
| Models, Statistical | 2 | 1996 | 5092 | 0.010 |
Why?
|
| Drug Administration Schedule | 2 | 2007 | 4853 | 0.010 |
Why?
|
| Diet Therapy | 1 | 2005 | 149 | 0.010 |
Why?
|
| Somatosensory Cortex | 1 | 2008 | 506 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 1991 | 2721 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2000 | 4356 | 0.010 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2008 | 878 | 0.010 |
Why?
|
| Prednisone | 1 | 1988 | 1566 | 0.010 |
Why?
|
| Cyclopropanes | 1 | 2005 | 436 | 0.010 |
Why?
|
| Electronics, Medical | 1 | 2003 | 70 | 0.010 |
Why?
|
| Oklahoma | 1 | 2003 | 36 | 0.010 |
Why?
|
| Southwestern United States | 1 | 2003 | 39 | 0.010 |
Why?
|
| Pneumococcal Vaccines | 1 | 2007 | 414 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2005 | 472 | 0.010 |
Why?
|
| Music Therapy | 1 | 2005 | 111 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 2 | 1996 | 1622 | 0.010 |
Why?
|
| Mexican Americans | 1 | 2004 | 165 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 1326 | 0.010 |
Why?
|
| Heart Murmurs | 1 | 2003 | 92 | 0.010 |
Why?
|
| HIV Seronegativity | 1 | 2004 | 209 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2009 | 2105 | 0.010 |
Why?
|
| Perception | 1 | 2009 | 1204 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 1991 | 2353 | 0.010 |
Why?
|
| Sickness Impact Profile | 1 | 2004 | 299 | 0.010 |
Why?
|
| Rest | 2 | 1998 | 940 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2013 | 4188 | 0.010 |
Why?
|
| Brachial Artery | 1 | 2004 | 373 | 0.010 |
Why?
|
| Leptin | 1 | 2010 | 1596 | 0.010 |
Why?
|
| Occupational Diseases | 1 | 1990 | 1456 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1999 | 9613 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2014 | 3208 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2009 | 2120 | 0.010 |
Why?
|
| Research | 1 | 1990 | 1977 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2005 | 1154 | 0.010 |
Why?
|
| Maternal Age | 1 | 2005 | 804 | 0.010 |
Why?
|
| Dyspnea | 2 | 2000 | 1352 | 0.010 |
Why?
|
| Sleep | 2 | 1996 | 4814 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2016 | 6422 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 2005 | 642 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2006 | 697 | 0.010 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2004 | 239 | 0.010 |
Why?
|
| Fellowships and Scholarships | 1 | 1990 | 1134 | 0.010 |
Why?
|
| Focus Groups | 1 | 2008 | 1459 | 0.010 |
Why?
|
| Suicidal Ideation | 1 | 2012 | 1467 | 0.010 |
Why?
|
| Inflammation | 1 | 2021 | 10863 | 0.010 |
Why?
|
| Intraoperative Complications | 2 | 1998 | 1171 | 0.010 |
Why?
|
| Treatment Failure | 2 | 1999 | 2659 | 0.010 |
Why?
|
| Pennsylvania | 1 | 2003 | 615 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2007 | 1241 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1993 | 2255 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2005 | 4047 | 0.010 |
Why?
|
| Markov Chains | 1 | 2005 | 974 | 0.010 |
Why?
|
| Movement | 2 | 1998 | 1468 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 2001 | 196 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2004 | 1478 | 0.010 |
Why?
|
| Menopause | 1 | 2009 | 1656 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1988 | 1794 | 0.010 |
Why?
|
| Age of Onset | 2 | 1999 | 3343 | 0.010 |
Why?
|
| Energy Intake | 2 | 2001 | 2142 | 0.010 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 1994 | 582 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2001 | 9101 | 0.010 |
Why?
|
| Causality | 1 | 2006 | 1252 | 0.010 |
Why?
|
| Reoperation | 2 | 2003 | 4325 | 0.010 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1999 | 138 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 2005 | 1828 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2003 | 915 | 0.010 |
Why?
|
| Transcription Factor DP1 | 1 | 1999 | 136 | 0.010 |
Why?
|
| Viral Load | 2 | 2001 | 3385 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1996 | 4747 | 0.010 |
Why?
|
| Vasodilation | 1 | 2004 | 968 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1999 | 12159 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 1993 | 897 | 0.010 |
Why?
|
| Contrast Media | 1 | 2013 | 5329 | 0.010 |
Why?
|
| Telemedicine | 1 | 2017 | 3111 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 2727 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2003 | 1374 | 0.010 |
Why?
|
| Life Tables | 1 | 1999 | 367 | 0.010 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 1990 | 1481 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1999 | 310 | 0.010 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2000 | 82 | 0.010 |
Why?
|
| Health Education | 1 | 2006 | 1060 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 1999 | 270 | 0.010 |
Why?
|
| Mitochondria, Heart | 1 | 2000 | 229 | 0.010 |
Why?
|
| Utilization Review | 1 | 2000 | 381 | 0.010 |
Why?
|
| Emergency Treatment | 1 | 2003 | 495 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1999 | 284 | 0.010 |
Why?
|
| Ventricular Function | 1 | 2000 | 403 | 0.010 |
Why?
|
| Subclavian Vein | 1 | 1998 | 57 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 1990 | 2418 | 0.010 |
Why?
|
| ROC Curve | 1 | 2006 | 3621 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2003 | 1674 | 0.010 |
Why?
|
| Uterine Hemorrhage | 1 | 1999 | 235 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2008 | 1949 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4570 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 2007 | 2463 | 0.010 |
Why?
|
| Syndrome | 1 | 2004 | 3271 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2003 | 1438 | 0.010 |
Why?
|
| Zalcitabine | 1 | 1997 | 43 | 0.010 |
Why?
|
| Chest Tubes | 1 | 1998 | 153 | 0.010 |
Why?
|
| Neopterin | 1 | 1997 | 57 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1991 | 3114 | 0.010 |
Why?
|
| AIDS Dementia Complex | 1 | 1998 | 154 | 0.010 |
Why?
|
| Counseling | 1 | 2005 | 1550 | 0.010 |
Why?
|
| Pharmaceutical Preparations | 1 | 2005 | 1086 | 0.010 |
Why?
|
| Electrooculography | 1 | 1996 | 112 | 0.010 |
Why?
|
| Hand Injuries | 1 | 1999 | 239 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1993 | 8928 | 0.010 |
Why?
|
| Health Facility Size | 1 | 1996 | 59 | 0.010 |
Why?
|
| Diet | 1 | 2014 | 8088 | 0.010 |
Why?
|
| Heart Block | 1 | 1998 | 391 | 0.010 |
Why?
|
| Heart Injuries | 1 | 1998 | 207 | 0.010 |
Why?
|
| Foot | 1 | 2000 | 576 | 0.010 |
Why?
|
| Edema | 1 | 2000 | 764 | 0.010 |
Why?
|
| North America | 1 | 2000 | 1287 | 0.010 |
Why?
|
| Laboratories, Hospital | 1 | 1997 | 192 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 1998 | 434 | 0.010 |
Why?
|
| Computer Systems | 1 | 1997 | 467 | 0.010 |
Why?
|
| Dysthymic Disorder | 1 | 1996 | 73 | 0.010 |
Why?
|
| Confusion | 1 | 1998 | 278 | 0.010 |
Why?
|
| Sentinel Surveillance | 1 | 1998 | 292 | 0.010 |
Why?
|
| Equipment Failure | 1 | 1998 | 585 | 0.010 |
Why?
|
| Parietal Lobe | 1 | 2001 | 860 | 0.010 |
Why?
|
| Emotions | 1 | 1987 | 2758 | 0.010 |
Why?
|
| Japan | 1 | 2000 | 1418 | 0.010 |
Why?
|
| Sick Role | 1 | 1996 | 229 | 0.010 |
Why?
|
| Craniocerebral Trauma | 1 | 1999 | 493 | 0.010 |
Why?
|
| Brain | 3 | 1999 | 27158 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2003 | 1521 | 0.010 |
Why?
|
| Wheelchairs | 1 | 1995 | 78 | 0.010 |
Why?
|
| Intraoperative Care | 1 | 1998 | 768 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2001 | 1469 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2005 | 2694 | 0.010 |
Why?
|
| Mothers | 1 | 2005 | 2208 | 0.010 |
Why?
|
| Pneumothorax | 1 | 1998 | 393 | 0.010 |
Why?
|
| Biopsy | 1 | 2006 | 6779 | 0.010 |
Why?
|
| Decision Trees | 1 | 1996 | 508 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 1998 | 642 | 0.010 |
Why?
|
| Animals | 3 | 2017 | 168939 | 0.010 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 1994 | 117 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2001 | 1408 | 0.010 |
Why?
|
| Necrosis | 1 | 1998 | 1614 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2005 | 2971 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2004 | 2120 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1999 | 996 | 0.010 |
Why?
|
| Lipids | 1 | 2005 | 3322 | 0.010 |
Why?
|
| Vagina | 1 | 1999 | 849 | 0.010 |
Why?
|
| Management Audit | 1 | 1993 | 23 | 0.010 |
Why?
|
| Radiology Department, Hospital | 1 | 1997 | 409 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1994 | 158 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2009 | 6613 | 0.010 |
Why?
|
| Models, Structural | 1 | 1993 | 339 | 0.010 |
Why?
|
| Specialty Boards | 1 | 1995 | 235 | 0.010 |
Why?
|
| HLA-DR2 Antigen | 1 | 1993 | 44 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 1999 | 962 | 0.010 |
Why?
|
| Catheterization, Central Venous | 1 | 1998 | 538 | 0.010 |
Why?
|
| Marijuana Abuse | 1 | 1997 | 409 | 0.010 |
Why?
|
| Lenses, Intraocular | 1 | 1994 | 141 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 2005 | 2085 | 0.010 |
Why?
|
| Drug Utilization | 1 | 1999 | 1188 | 0.010 |
Why?
|
| Organ Size | 1 | 1997 | 2262 | 0.010 |
Why?
|
| Vision, Ocular | 1 | 1995 | 457 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1993 | 655 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1994 | 416 | 0.010 |
Why?
|
| Tissue Adhesions | 1 | 1993 | 222 | 0.010 |
Why?
|
| Ovarian Diseases | 1 | 1993 | 133 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2003 | 1936 | 0.010 |
Why?
|
| Amylases | 1 | 1992 | 171 | 0.010 |
Why?
|
| Emergencies | 1 | 1998 | 1223 | 0.010 |
Why?
|
| Herpesviridae Infections | 1 | 1993 | 268 | 0.010 |
Why?
|
| Transfection | 1 | 1999 | 5755 | 0.010 |
Why?
|
| Xylose | 1 | 1991 | 28 | 0.010 |
Why?
|
| Lactose Intolerance | 1 | 1991 | 28 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 4968 | 0.010 |
Why?
|
| Injections, Epidural | 1 | 1993 | 203 | 0.010 |
Why?
|
| Analgesia, Epidural | 1 | 1994 | 332 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2008 | 20710 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 1988 | 5130 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1991 | 370 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 1992 | 527 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 1994 | 608 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1994 | 676 | 0.010 |
Why?
|
| Job Description | 1 | 1990 | 61 | 0.010 |
Why?
|
| Cattle | 1 | 1996 | 3815 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 1982 | 2590 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 12795 | 0.010 |
Why?
|
| Breath Tests | 1 | 1991 | 297 | 0.010 |
Why?
|
| Wechsler Scales | 1 | 1990 | 256 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1993 | 913 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 1992 | 591 | 0.010 |
Why?
|
| Neural Pathways | 1 | 2001 | 3079 | 0.010 |
Why?
|
| Computer Simulation | 2 | 1994 | 6258 | 0.010 |
Why?
|
| Lipase | 1 | 1992 | 320 | 0.010 |
Why?
|
| Respiratory Sounds | 1 | 1994 | 702 | 0.010 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1993 | 663 | 0.010 |
Why?
|
| Placebo Effect | 1 | 1993 | 515 | 0.010 |
Why?
|
| Wakefulness | 1 | 1996 | 1282 | 0.010 |
Why?
|
| Gait | 1 | 1995 | 823 | 0.010 |
Why?
|
| Cataract | 1 | 1995 | 837 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 1995 | 908 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 1994 | 915 | 0.010 |
Why?
|
| Opportunistic Infections | 1 | 1992 | 376 | 0.000 |
Why?
|
| Leukemia | 1 | 1997 | 1521 | 0.000 |
Why?
|
| Graft Survival | 1 | 1999 | 3904 | 0.000 |
Why?
|
| Fertility | 1 | 1993 | 770 | 0.000 |
Why?
|
| Stroke Volume | 1 | 2002 | 5618 | 0.000 |
Why?
|
| Models, Cardiovascular | 1 | 1993 | 978 | 0.000 |
Why?
|
| Aortic Valve | 1 | 1998 | 1966 | 0.000 |
Why?
|
| Tobacco Smoke Pollution | 1 | 1994 | 828 | 0.000 |
Why?
|
| Leukopenia | 1 | 1988 | 213 | 0.000 |
Why?
|
| Herpesvirus 4, Human | 1 | 1993 | 1080 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1999 | 3464 | 0.000 |
Why?
|
| Anesthesia | 1 | 1998 | 1595 | 0.000 |
Why?
|
| Nurse Practitioners | 1 | 1990 | 270 | 0.000 |
Why?
|
| Self Administration | 1 | 1988 | 386 | 0.000 |
Why?
|
| Cytomegalovirus Infections | 1 | 1993 | 838 | 0.000 |
Why?
|
| Haplotypes | 1 | 1993 | 2726 | 0.000 |
Why?
|
| Infusions, Intravenous | 1 | 1990 | 2228 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1994 | 2606 | 0.000 |
Why?
|
| T-Lymphocytes | 2 | 1993 | 10263 | 0.000 |
Why?
|
| Sex Characteristics | 1 | 1996 | 2645 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1993 | 1838 | 0.000 |
Why?
|
| Hepatitis B | 1 | 1990 | 710 | 0.000 |
Why?
|
| Heart Arrest | 1 | 1993 | 1516 | 0.000 |
Why?
|
| Steroids | 1 | 1987 | 936 | 0.000 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1991 | 2571 | 0.000 |
Why?
|
| Societies, Medical | 1 | 1993 | 3957 | 0.000 |
Why?
|
| Air Pollution | 1 | 1994 | 2377 | 0.000 |
Why?
|
| Education, Medical | 1 | 1990 | 1744 | 0.000 |
Why?
|
| Body Temperature | 1 | 1982 | 780 | 0.000 |
Why?
|
| Curriculum | 1 | 1990 | 3783 | 0.000 |
Why?
|